LCMS webinars focusing on Dissolution - page 2

The discussion will highlight some advantages and disadvantages of PQ and MQ approaches and give you some insights on which approach could work best for your lab.

Release profile of poly (lactic co-glycolic) (PLGA) nanocapsules loaded with all-trans retinoic acid (RA). Dissolution Studies with NanoDis

Release-rate testing basics and method development considerations for cannabis-related products.

Key aspects of the dissolution workflow that can be accelerated to produce data faster and reduce overall time between tests.

Do you wish to quickly uncover the best nanoparticle formulation, and achieve accurate and reliable results in any dissolution tests for tablets or liposome drug products?

This presentation covers the basics of adapting the dissolution environment for low-dose, extended-release dosage forms (e.g., medical devices).

How to implement quick and proactive measures to reduce and even prevent failures from occurring in the dissolution environment.

Biorelevant Dissolution media has long been a topic of drug release testing and has become a stronger focus in the pharmaceutical industry.

How does the Dissolution workflow and equipment fit into the move to a connected lab environment and where do we see challenges but also opportunities?

Does Amino Acid analysis impact different stages of drug discovery or the manufacturing process? Is it important for protein and peptide identification and quantitation?​